Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
JWTCR001
/
Medigene, Regeneron
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
||
||||||||
JWTCR001
/
Medigene, Regeneron
New P1 trial:
MAGE-A4-directed TCR-T in the Treatment Amongst Subjects With Advanced Solid Tumors
(clinicaltrials.gov) - Dec 14, 2023
P1
, N=20, Recruiting,
Sponsor: Peking University